Mirabegron and Colchicine: Interaction Details
- Mirabegron
- Myrbetriq
- Colchicine
- ColcrysGloperbaMitigare +1 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Mirabegron and Colchicine interaction:
Colchicine
- Colcrys
- Gloperba
- Mitigare
- Lodoco
What Happens When You Take Mirabegron With Colchicine
What can happen when they are taken together (rated Contraindicated)
Increased colchicine exposure and an increased risk of colchicine toxicity
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Colchicine must not be combined with (eg, rifampin) in patients who have established atherosclerotic disease or multiple cardiovascular risk factors and who take 0.5 mg once daily, since life-threatening and fatal colchicine toxicity has been reported in such patients at therapeutic colchicine doses.1 The combination is likewise for gout prophylaxis and treatment when the patient has or impairment.2
Dose adjustments for other patient populations, indications, and/or dosage regimens are covered under Quick Answers - Dose Adjustments in the colchicine monograph. To lower the risk of adverse events from colchicine drug interactions, one can substitute an alternative therapy for the interacting drug, discontinue colchicine while the interacting drug is in use, or, when the two drugs cannot be kept apart, lower the colchicine dose.3
Rifampin both inhibits and induces P-gp. Its first effect is P-gp , but with repeated dosing this inhibitory action fades and its inducing effect becomes the dominant one.4
The Mirabegron and Colchicine Interaction, Explained
Mirabegron (Myrbetriq) can raise the amount of colchicine in your body. Mirabegron may block a pump called that helps clear colchicine, so colchicine can build up. Too much colchicine can cause serious problems, including severe stomach upset, muscle damage, and blood problems. Reports of life-threatening toxicity exist even at normal doses in some people, such as those with heart disease risk factors, kidney problems, or liver problems.
The evidence for this is rated as probable. Please do not stop or change either medicine on your own. Tell your pharmacist or doctor that you take both, so your care team can choose an alternative, pause one drug, or adjust and individualize the colchicine dose and monitor you more closely.
Mechanism: Mirabegron is a (moderate), which may reduce P-gp-mediated colchicine efflux, increasing colchicine exposure (/) and toxicity risk. Colchicine has a , so small changes in exposure matter. Neither drug is affected as a .
- Severity/evidence: Listed as ; evidence probable; onset unspecified.
- Contraindicated: P-gp with colchicine 0.5 mg daily in patients with established ASCVD or multiple CV risk factors (fatal toxicity reported at therapeutic doses), and for gout prophylaxis/treatment in or impairment.
- Management: Use an alternative to the interacting drug, hold colchicine during use, or if is unavoidable, reduce the colchicine dose (see colchicine monograph dose adjustments). Monitor for toxicity, , and cytopenias.
See the 7 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Mirabegron and Colchicine Interact
The likely mechanism
of -mediated colchicine efflux transport
How to Manage the Mirabegron and Colchicine Interaction
Your care team can manage this, and the approach depends on why you take colchicine and your kidney and liver health.
- Keep taking both exactly as prescribed until your pharmacist or prescriber advises you otherwise.
- Your team may choose an alternative to mirabegron, pause colchicine while you take it, or, if both are needed, reduce and individualize the colchicine dose.
- Your team may monitor you more closely.
- Tell them about any kidney or liver problems, heart disease, or risk factors for it.
- Report severe diarrhea, vomiting, muscle pain or weakness, or unusual bruising promptly.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Mirabegron or Colchicine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
4 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
A systematic review and classification of the effects of P-glycoprotein inhibitors and inducers in humans, using digoxin, fexofenadine, and dabigatran as probe drugs
A systematic review of 151 studies evaluated how and affect the concentration time profile of P-gp , and identified rifampin as a drug with short-term inhibitory and time-dependent inductive effects. Rifampicin initially functions as a P-gp , raising the area under the curve ratio (AUCR) of the probe substrates digoxin (1.31 to 1.46) and dabigatran (2.08 to 2.22). After multiple doses, however, the AUCR was reduced, ranging from 0.68 to 1 for digoxin and 0.33 to 0.59 for dabigatran.4
-
Report 2 · Study title
Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical drug-drug interaction studies
A review article describing the effect of on P-gp exposure found rifampin to be the most potent P-gp , with an average reduction in substrate exposure of 20% to 67%. Only studies in which rifampin administration was staggered relative to the P-gp substrate were included, since rifampin acts as a mixed /inducer of P-gp.
Giving rifampin during the phase of the P-gp substrate may cause intestinal , which confounds the assessment of P-gp . Rifampin lowered the of orally administered substrates by 19% to 69.5%, while did not change, suggesting that the effect of rifampin on the P-gp substrate is mainly attributable to P-gp induction in the intestine, with minimal effect on renal P-gp.5
-
Report 3 · Study title
Prescribing information: GLOPERBA oral solution, colchicine oral solution
In a study (N=19 to 21), of carvedilol phosphate (a ) did not affect the of colchicine, although the geometric mean ratio of colchicine (0 to last) was 118% (90% CI, 112% to 124%). Patients received carvedilol 20 mg daily on Days 11 to 12, then 40 mg daily on Days 13 to 17, and received colchicine 0.6 mg on Day 17. These results should not be extrapolated to other P-gp , because colchicine is a known P-gp and case reports have been published of colchicine toxicity associated with coadministration of P-gp inhibitors (ie, cyclosporine).6
-
Report 4 · Study title
Prescribing information: MITIGARE oral capsules, colchicine oral capsules
In a study of healthy volunteers, of colchicine with propafenone (a ) 225 mg twice daily for 5 days produced no changes in systemic colchicine levels. These results should nonetheless not be extrapolated to other P-gp , because colchicine is a known P-gp and case reports have been published of colchicine toxicity associated with coadministration of P-gp inhibitors such as cyclosporine.7
Mirabegron and Colchicine: Common Questions
How serious is the Mirabegron and Colchicine interaction?
It is rated . These should generally not be used together.
How is the Mirabegron and Colchicine interaction managed?
Your care team can manage this, and the approach depends on why you take colchicine and your kidney and liver health. Keep taking both exactly as prescribed until your pharmacist or prescriber advises you otherwise. Your team may choose an alternative to mirabegron, pause colchicine while you take it, or, if both are needed, reduce and individualize the colchicine dose. Your team may monitor you m… Management is individual — always follow your own care team's guidance.
Who is at higher risk from the Mirabegron and Colchicine interaction?
The interaction record names these groups as more likely to be affected:
- People with liver problems
- People with heart disease or heart failure
If this describes you, tell your pharmacist or prescriber.
Is there an alternative to taking Mirabegron with Colchicine?
Your team may choose an alternative to mirabegron, pause colchicine while you take it, or, if both are needed, reduce and individualize the colchicine dose.
Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Mirabegron and Colchicine Interaction
Ask in your own words about taking Mirabegron and Colchicine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (7)
- Product Information: LODOCO(R) oral tablets, colchicine oral tablets. AGEPHA Pharma USA, LLC (per FDA), Parsippany, NJ, 2023. DailyMed
- Product Information: COLCRYS oral tablets, colchicine oral tablets. Takeda Pharmaceuticals America Inc (per FDA), Deerfield, IL, 2020. DailyMed
- Hansten PD, Tan MS, Horn JR, et al: Colchicine drug interaction errors and misunderstandings: recommendations for improved evidence-based management. Drug Saf 2023; 46(3):223-242. PubMed
- Coumau C & Csajka C: A systematic review and classification of the effects of P-glycoprotein inhibitors and inducers in humans, using digoxin, fexofenadine, and dabigatran as probe drugs. Clin Pharmacokinet 2025; 64(6):849-863. DOI
- Elmeliegy M, Vourvahis M, Guo C, et al: Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical drug-drug interaction studies. Clin Pharmacokinet 2020; 59(6):699-714. PubMed
- Product Information: GLOPERBA(R) oral solution, colchicine oral solution. Romeg Therapeutics LLC (per FDA), Woburn, MA, 2019. DailyMed
- Product Information: MITIGARE(R) oral capsules, colchicine oral capsules. Hikma Specialty USA Inc (per FDA), Columbus, OH, 2024. DailyMed
Other Serious Interactions of Mirabegron and Colchicine
Also serious with Mirabegron
Also serious with Colchicine
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Mirabegron
- Activated CharcoalMajor
- Slippery ElmModerate
- YohimbeModerate
- GlucomannanModerate
- TragacanthModerate
- Coffee CharcoalModerate
- European MandrakeModerate
- Fever BarkModerate
- + 12 more
With Colchicine
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- Autumn CrocusMajor
- Vitamin EModerate
- GingerModerate
- TurmericModerate
- Green TeaModerate
- + 143 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together. This interaction.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.